Hints and tips:
...German conglomerate Bayer is trapped in a long-running legal battle in the US following its $63bn acquisition in 2016 of seed maker Monsanto, which left the group exposed to litigation over allegedly cancerous...
...“[Investors] have been fairly traumatised by the Bayer Monsanto situation and the Johnson & Johnson talc litigation,” said Bernstein analyst Lisa Clive, referring to two recent multibillion-dollar payouts...
...A version of this article was first published by Nikkei Asia on April 10, 2021. ©2021 Nikkei Inc. All rights reserved....
...Elsewhere, Bayer’s shares have dropped by more than one-third over the past year, as it faces legal claims from cancer patients relating to weedkillers it bought as part of its acquisition of US firm Monsanto...
...One thing to start: Bayer will pay up to $10.9bn to settle a wave of lawsuits over the potential carcinogenic effects of its pesticide product Roundup, relating to its takeover of US agrichemical company Monsanto...
...April last year, BlackRock refused to back the board of German pharmaceutical group Bayer at the company’s annual meeting, in a largely symbolic protest over its handling of a merger with pesticides-maker Monsanto...
...Investors fled the drugmaker’s stock in droves once the high price for Monsanto was announced....
...Roughly one-third of the 30 companies in the Dax index are suffering from some kind of snafu, ranging from Deutsche Bank’s excessive ambitions to Bayer’s disastrous acquisition of Monsanto, which gave it...
...Bayer, for instance, has struggled since digesting its Monsanto purchase, with its market value falling by more than $45bn since the deal.....
UK Prime Minister Theresa May makes a big gamble that risks a no-deal Brexit, the Fe…
...The once purring engine of Germany Inc is sputtering. Bayer faces investor fury over its disastrous Monsanto takeover....
...That has fuelled a perception that Germany Inc. remains a closed shop for insiders....
...Chemical group Bayer is in trouble over last year’s $63bn acquisition of US rival Monsanto, whose herbicides have been linked in court cases to cancer....
...“They want to make sure it’s a sleepy, boring bond-like equity, not something that will turn into Bayer with Monsanto,” he says, referring to the German chemical company’s legal battles over whether its...
...(Bloomberg) Bayer’s headache After lots of recent coverage over the horrific reality at Germany’s Bayer following its takeover of US-based Monsanto, The Wall Street Journal is out with a nice chart-led...
...The fee collected by Goldman is lower than the $120m brought in by Morgan Stanley for advising Monsanto in its $66bn sale to Germany’s Bayer, which was the highest advisory fee paid to an investment bank...
...Bayer had to offer US competition regulators large concessions to secure approval for its $63bn takeover of Monsanto. Bond investors have been less demanding....
...SoftBank in talks to invest $10bn in WeWork (FT) Natixis payments explores Ingenico takeover bid (BBG) Aviva chief pays price for muddled strategic message (FT) Bayer weighs selling its vet unit in post-Monsanto...
...However, it now expects the Monsanto deal to result in a maximum downgrade of two notches....
...same approach when it agreed to sell two parcels of assets for about €7.5bn during the EU’s merger review process in an effort to more quickly obtain antitrust approval for its €66bn takeover of US rival Monsanto...
...Monsanto was up 0.3 per cent Food producers were faring better, with many analysts surmising tariff action could depress soft commodity prices, thereby driving down the cost of inputs for such companies...
...Monsanto said it “continues to be confident in the companies’ collective ability to secure the required approvals within the second calendar quarter of 2018 and in the time contemplated by the agreement”...
...Shares in Bayer shed a 10th of their market value (about $10bn) on Monday as investors feared a possible avalanche of costly legal defeats linked to a weedkiller made by Monsanto, the US rival it acquired...
...Bayer is busy with an all-cash takeover of Monsanto. Swiss conservatism could impede Nestlé....
...As well as those deals, CVS’s $68bn takeover of Aetna, Bayer’s $57bn purchase of Monsanto and United Technologies $30bn bid for Rockwell Collins all need to be funded in the US debt market this year....
International Edition